Hull University Teaching Hospital

Hull HU32RW

0 studies enrolling now · 4 studies all time

What they study most

Acute Ischemic Stroke, Diabetes Mellitus, Type 2, Hypothalamic Obesity, Ischemic Stroke, NASH - Nonalcoholic Steatohepatitis, Stroke, Acute

Studies at this site

• A Trial of Setmelanotide in Acquired Hypothalamic Obesity — Running, not enrolling
• EndovaSCular TreAtment to imProve outcomEs for Medium Vessel Occlusions (ESCAPE-MeVO Trial) — Running, not enrolling
• Placebo-controlled, Proof-of-concept Study to Evaluate the Safety and Efficacy of Lanifibranor Alone and in Combination With SGLT2 Inhibitor EmpaGliflozin in patiEnts With NASH and Type 2 Diabetes Mellitus — Completed
• Tenecteplase in Wake-up Ischaemic Stroke Trial — Status unconfirmed